These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20924409)

  • 1. Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.
    Bonaïti B; Bonadona V; Perdry H; Andrieu N; Bonaïti-Pellié C
    Eur J Hum Genet; 2011 Feb; 19(2):173-9. PubMed ID: 20924409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.
    Carayol J; Bonaïti-Pellié C
    Genet Epidemiol; 2004 Sep; 27(2):109-17. PubMed ID: 15305327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating cancer risk in HNPCC by the GRL method.
    Alarcon F; Lasset C; Carayol J; Bonadona V; Perdry H; Desseigne F; Wang Q; Bonaïti-Pellié C
    Eur J Hum Genet; 2007 Aug; 15(8):831-6. PubMed ID: 17473834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.
    Gong G; Whittemore AS
    Genet Epidemiol; 2003 Apr; 24(3):173-80. PubMed ID: 12652521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating successive cancer risks in Lynch Syndrome families using a progressive three-state model.
    Choi YH; Briollais L; Green J; Parfrey P; Kopciuk K
    Stat Med; 2014 Feb; 33(4):618-38. PubMed ID: 23946183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First estimates of diffuse gastric cancer risks for carriers of
    Coudert M; Drouet Y; Delhomelle H; Svrcek M; Benusiglio PR; Coulet F; Clark DF; Katona BW; van Hest LP; van der Kolk LE; Cats A; van Dieren JM; Nehoray B; Slavin T; Spier I; Hüneburg R; Lobo S; Oliveira C; Boussemart L; Masson L; Chiesa J; Schwartz M; Buecher B; Golmard L; Bouvier AM; Bonadona V; Stoppa-Lyonnet D; Lasset C; Colas C
    J Med Genet; 2022 Dec; 59(12):1189-1195. PubMed ID: 36038258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the penetrance of pathogenic gene variants in families with missing pedigree information.
    Jonker MA; Rijken JA; Hes FJ; Putter H; Hensen EF
    Stat Methods Med Res; 2019; 28(10-11):2924-2936. PubMed ID: 30073909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating disease risk associated with mutated genes in family-based designs.
    Choi YH; Kopciuk KA; Briollais L
    Hum Hered; 2008; 66(4):238-51. PubMed ID: 18612208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred.
    Vogl FD; Badzioch MD; Steele L; Neuhausen SL; Goldgar DE
    Fam Cancer; 2007; 6(1):63-71. PubMed ID: 17051349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonparametric method for penetrance function estimation.
    Alarcon F; Bonaïti-Pellié C; Harari-Kermadec H
    Genet Epidemiol; 2009 Jan; 33(1):38-44. PubMed ID: 18618769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations.
    Michelucci R; Pasini E; Malacrida S; Striano P; Bonaventura CD; Pulitano P; Bisulli F; Egeo G; Santulli L; Sofia V; Gambardella A; Elia M; de Falco A; Neve Al; Banfi P; Coppola G; Avoni P; Binelli S; Boniver C; Pisano T; Marchini M; Dazzo E; Fanciulli M; Bartolini Y; Riguzzi P; Volpi L; de Falco FA; Giallonardo AT; Mecarelli O; Striano S; Tinuper P; Nobile C
    Epilepsia; 2013 Jul; 54(7):1288-97. PubMed ID: 23621105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the use of familial aggregation in population-based case probands for calculating penetrance.
    Begg CB
    J Natl Cancer Inst; 2002 Aug; 94(16):1221-6. PubMed ID: 12189225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.
    Alarcon F; Bourgain C; Gauthier-Villars M; Planté-Bordeneuve V; Stoppa-Lyonnet D; Bonaïti-Pellié C
    Genet Epidemiol; 2009 Jul; 33(5):379-85. PubMed ID: 19089844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of genetic risk function with covariates in the presence of missing genotypes.
    Lee AJ; Marder K; Alcalay RN; Mejia-Santana H; Orr-Urtreger A; Giladi N; Bressman S; Wang Y
    Stat Med; 2017 Sep; 36(22):3533-3546. PubMed ID: 28656686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robustness of inference on measured covariates to misspecification of genetic random effects in family studies.
    Pfeiffer RM; Hildesheim A; Gail MH; Pee D; Chen CJ; Goldstein AM; Diehl SR
    Genet Epidemiol; 2003 Jan; 24(1):14-23. PubMed ID: 12508252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?
    Roberts SA; Spreadborough AR; Bulman B; Barber JB; Evans DG; Scott D
    Am J Hum Genet; 1999 Sep; 65(3):784-94. PubMed ID: 10441587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating gene penetrance from family data.
    Gong G; Hannon N; Whittemore AS
    Genet Epidemiol; 2010 May; 34(4):373-81. PubMed ID: 20397150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
    Chen S; Iversen ES; Friebel T; Finkelstein D; Weber BL; Eisen A; Peterson LE; Schildkraut JM; Isaacs C; Peshkin BN; Corio C; Leondaridis L; Tomlinson G; Dutson D; Kerber R; Amos CI; Strong LC; Berry DA; Euhus DM; Parmigiani G
    J Clin Oncol; 2006 Feb; 24(6):863-71. PubMed ID: 16484695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
    Bishop JA; Wachsmuth RC; Harland M; Bataille V; Pinney E; MacK P; Baglietto L; Cuzick J; Bishop DT
    J Invest Dermatol; 2000 Jan; 114(1):28-33. PubMed ID: 10620111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.